156 results
8-K
EX-10.1
RGLS
Regulus Therapeutics Inc
14 Mar 24
Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity
4:57pm
basis throughout the periods involved except, in the case of unaudited interim financial statements, for normal year-end audit adjustments … statements (subject, in the case of unaudited statements, to normal and recurring year-end audit adjustments).
4.4 Securities Laws Disclosure; Publicity
8-K
xn2bn0ugk679kd4b
14 Jun 23
Departure of Directors or Certain Officers
4:01pm
DEFA14A
p582tixfew6 zd5
28 Apr 23
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
3f8mr3s4b940bfsiw
13 Apr 23
Securities Purchase Agreement
4:05pm
8-K
tj5yg 85q3zt
13 Jun 22
Departure of Directors or Certain Officers
4:08pm